Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 54 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9334244

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 10, 2016 · Expires May 5, 2036

    granted
  2. US 9328129

    Peptidomimetic inhibitors of PSMA

    The Regents of the University of California · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  3. US 9328142

    Lipopeptide inhibitors of RAS oncoproteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  4. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  5. US 9320734

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  6. US 9321763

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  7. US 9309279

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  8. US 9309237

    HIV inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  9. US 9309231

    Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  10. US 9309250

    Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  11. US 9309232

    Synthesis of novel inhibitors of isoprenoid biosynthesis

    Beryllium Discovery Corp. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  12. US 9303061

    Spiro compounds as Hepatitis C virus inhibitors

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted
  13. US 9303042

    Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted
  14. US 9301947

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted
  15. US 9296701

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted
  16. US 9296730

    Aurora kinase inhibitors

    Regents of the University of Minnesota · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted
  17. US 9296693

    Acyl piperidine inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted
  18. US 9290456

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted
  19. US 9271962

    Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors

    Northwestern University · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  20. US 9265734

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  21. US 9260416

    Heterocyclic autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  22. US 9260414

    Inhibitors of hepatitic C virus

    Theravance Biopharma R&D IP, LLC · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  23. US 9249473

    Compositions and methods for the identification of inhibitors of retroviral infection

    TRANA DISCOVERY, INC. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  24. US 9248119

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted